Literature DB >> 6729815

State of sulfhydryl in selenite cataract.

L L David, T R Shearer.   

Abstract

A dose of 20 mumol selenite/kg body weight is a potent and a very rapid inducer of cataracts in young rats. We investigated the rate at which physiological concentrations of selenite would catalyze the oxidation of glutathione in vitro and found that selenite was a strong sulfhydryl oxidant. To test if selenite had the same effect in vivo, the oxidation state of five kinds of lenticular sulfur were measured in suckling rats following a cataractous dose of selenite. The measurements included reduced glutathione (GSH), oxidized glutathione (GSSG), protein-bound glutathione ( PSSG ), reduced protein sulfhydryl ( PSH ), and oxidized protein sulfhydryl ( PSSP ). While selenite caused a 44% decrease in lens GSH by 6 days postinjection, there was no concurrent increase in either GSSG or PSSG . Likewise, there was no evidence for increased oxidation of PSH to PSSP . To determine if GSH loss were the cause of the selenite cataracts, we injected normal rats with the glutathione synthesis inhibitor buthionine sulfoximine (BSO). Lens GSH dropped more than 96% by 4 days post-BSO injection; however, no cataracts formed. Thus, selenite cataract does not appear to be caused by extensive sulfhydryl oxidation and cannot be attributed exclusively to GSH loss.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729815     DOI: 10.1016/0041-008x(84)90276-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  13 in total

1.  Identification of peptides in human Hsp20 and Hsp27 that possess molecular chaperone and anti-apoptotic activities.

Authors:  Rooban B Nahomi; Michael A DiMauro; Benlian Wang; Ram H Nagaraj
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

2.  Amelioration of selenite toxicity and cataractogenesis in cultured rat lenses by Vitex negundo.

Authors:  B N Rooban; V Sasikala; V Sahasranamam; Annie Abraham
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-15       Impact factor: 3.117

3.  Proposed Role for Internal Lens Pressure as an Initiator of Age-Related Lens Protein Aggregation Diseases.

Authors:  Alan N Glazier
Journal:  Clin Ophthalmol       Date:  2022-07-27

4.  Photoprotective effect of yellow-tinted intraocular lenses.

Authors:  Koichiro Mukai; Hiroyuki Matsushima; Muneaki Sawano; Hideho Nobori; Yoshitaka Obara
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

5.  Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts.

Authors:  Rooban B Nahomi; Benlian Wang; Cibin T Raghavan; Oliver Voss; Andrea I Doseff; Puttur Santhoshkumar; Ram H Nagaraj
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

6.  Phase-separation inhibitors and prevention of selenite cataract.

Authors:  J I Clark; J E Steele
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 7.  Glutathione dysregulation and the etiology and progression of human diseases.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Sylvia Notenboom; Shujie Shi; Kim Tieu; Christine L Hammond
Journal:  Biol Chem       Date:  2009-03       Impact factor: 3.915

8.  Regulatory effect of chrysin on expression of lenticular calcium transporters, calpains, and apoptotic-cascade components in selenite-induced cataract.

Authors:  Mahalingam Sundararajan; Philip A Thomas; P Archana Teresa; Muniyandi Anbukkarasi; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

9.  Saffron administration prevents selenite-induced cataractogenesis.

Authors:  Olga E Makri; Anastasia-Varvara Ferlemi; Fotini N Lamari; Constantine D Georgakopoulos
Journal:  Mol Vis       Date:  2013-05-30       Impact factor: 2.367

10.  Hesperetin prevents selenite-induced cataract in rats.

Authors:  Yosuke Nakazawa; Mikako Oka; Masayasu Bando; Makoto Takehana
Journal:  Mol Vis       Date:  2015-07-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.